Glaucoma, Vision & Longevity: Supplements & Science
Discover the latest science on glaucoma, vision, and longevity. Each episode explores evidence-based supplements for eye health, healthy aging, and lifespan extension. Original articles backed by real scientific research. All source links available at visualfieldtest.com, where you can also take a free visual field test online. Subscribe for weekly insights on glaucoma treatment, glaucoma prevention, vision supplements, and longevity research that could protect your sight and extend your healthspan.
MEDICAL DISCLAIMER:
This podcast is for educational and informational purposes only. It is not intended as medical advice, diagnosis, or treatment. The content presented should not replace professional medical consultation.
Glaucoma is a serious condition that can lead to permanent vision loss. Never stop or modify prescribed treatments without consulting your ophthalmologist or healthcare provider.
The supplements and research discussed are for informational purposes only. Individual results may vary, and supplements are not FDA-approved to treat, cure, or prevent any disease.
Always consult a qualified healthcare professional before starting any new supplement regimen, especially if you have existing eye conditions or are taking medications.
The visual field test available at visualfieldtest.com is a screening tool only and does not replace comprehensive eye exams by a licensed professional.
Glaucoma, Vision & Longevity: Supplements & Science
How Fast Is AI Actually Progressing, and What Does It Mean for Glaucoma Patients and Researchers?
Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.
This audio article is from VisualFieldTest.com.
Read the full article here: https://visualfieldtest.com/en/how-fast-is-ai-actually-progressing-and-what-does-it-mean-for-glaucoma-patients-and-researchers
Test your visual field online: https://visualfieldtest.com
Support the show so new episodes keep coming: https://www.buzzsprout.com/2563091/support
Excerpt:
How Fast Is AI Actually Progressing, and What Does It Mean for Glaucoma Patients and Researchers?Artificial intelligence (AI) has been advancing at breakneck speed in recent years. New AI models now perform tasks once thought years away, and these leaps are reflected in benchmarks, products, and research breakthroughs across many fields – including eye care. This article examines concrete measures of AI progress and translates them into what they mean for glaucoma care and research. We highlight real examples of AI tools already helping patients, summarize what new developments are on the horizon (from clinical trials to near-future innovations), and suggest questions patients and researchers can explore today to prepare for tomorrow’s advances. How is AI Progress Measured (and How Fast Is It Growing)?Researchers measure AI progress by performance on challenging tasks (benchmarks) and by tracking improvements in model design, data, and compute. In the last few years, all three of these factors have exploded. For example, one analysis found that the “frontier” of AI capabilities accelerated sharply around 2024 – roughly doubling its rate of improvement compared to prior years () (). In basic terms, AI systems can now solve problems almost twice as fast or as well as they could just a couple of years ago. Why is this happening? Since 2010, the computing power used to train leading AI models has roughly doubled every six months (), creating a 4–5× growth in compute per year. Training data sets (like text or images) have also been exploding – data sets roughly triple in size each year (). At the same time, model sizes (number of parameters) have been doubling annually. These three trends – massive compute, massive data, massive models – combine to create what some call a “trifecta” of rapid AI scaling (). The result is that capabilities often jump in swarms. State-of-the-art AI models that struggled with basic reasoning tasks even a couple of years ago are now solving mathematically complex problems, generating realistic images on demand, and even engaging in fluent medical knowledge conversations. For example, large language models (LLMs) like OpenAI’s GPT series have shown sudden leaps in abilities at specific size thresholds (). Each new generation (GPT-3 → GPT-4 → GPT-4.5, etc.) has outperformed the last on a wide range of benchmarks. Specialized systems for vision (image) tasks have also surged, with diffusion models and neural networks now producing realistic images or detecting subtle patterns with unprecedented accuracy. In short, the pace of improvement is not a slow linear climb – it’s accelerating in both raw metrics and real-world impact () (). Key takeaway: AI progress is concrete and measurable, and in the last 2–3 years performance on standard benchmarks and practical tasks has nearly doubled. This means new tools that were science fiction a decade ago are arriving faster than many expect.AI in Glaucoma Care TodayGlaucoma is a leading cause of irreversible vision loss worldwide, and it’s increasingly clear that AI can help us detect and manage it. Several AI-powered tools are already making their way into practice or close to it:AI-enhanced